These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9715413)
1. From a choleretic to an immunomodulator: historical review of ursodeoxycholic acid as a medicament. Makino I; Tanaka H J Gastroenterol Hepatol; 1998 Jun; 13(6):659-64. PubMed ID: 9715413 [No Abstract] [Full Text] [Related]
3. [The characteristics of the use of ursodeoxycholic acid in chronic diseases of the hepatobiliary system]. Dehtiar'ova II; Chernenko VV; Anokhina HA; Opanasiuk ND; Pavlik-Novol's'kyĭ T; Haĭsenko AV Lik Sprava; 1995; (9-12):47-8. PubMed ID: 8983789 [No Abstract] [Full Text] [Related]
8. Ursodeoxycholic acid after liver transplantation: does conjugation with taurine make the difference? Beuers U Ital J Gastroenterol Hepatol; 1999; 31(6):469-71. PubMed ID: 10575564 [No Abstract] [Full Text] [Related]
9. [New aspects of pharmacological effects of ursodeoxycholic acid]. Radchenko VG; Seliverstov PV; Sitkin SI Eksp Klin Gastroenterol; 2014; (8):4-10. PubMed ID: 25911905 [TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid in the treatment of liver diseases. Saksena S; Tandon RK Postgrad Med J; 1997 Feb; 73(856):75-80. PubMed ID: 9122101 [TBL] [Abstract][Full Text] [Related]
11. [Hepatobiliary lesions in Crohn's disease and conservative methods of treatment]. Grigor'eva GA; Meshalkina NIu Eksp Klin Gastroenterol; 2013; (6):3-6. PubMed ID: 24772851 [No Abstract] [Full Text] [Related]
12. Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease. Matsuda Y; Inada M; Maeda H; Matsuyama T Intern Med; 2002 Oct; 41(10):774-9. PubMed ID: 12412994 [TBL] [Abstract][Full Text] [Related]
13. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases. Trauner M; Graziadei IW Aliment Pharmacol Ther; 1999 Aug; 13(8):979-96. PubMed ID: 10468672 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of chronic inflammatory diseases of the biliary tract in children with the new choleretic drug Stachyren]. Shmorgun SS; Zinchenko TV; Kuz'menko IA Farm Zh; 1971; 26(6):48-50. PubMed ID: 5150543 [No Abstract] [Full Text] [Related]
19. Examining the increased IgM production and ursodeoxycholic acid treatment in PBC. Lazaridis KN; Larusso NF Gastroenterology; 2005 Feb; 128(2):498-500. PubMed ID: 15685560 [No Abstract] [Full Text] [Related]
20. The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis. Kaplan MM Semin Liver Dis; 1997 May; 17(2):129-36. PubMed ID: 9170200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]